France / Français
Only higher-dose tramadol outperforms placebo for improved pain, function in knee, hip OA
A daily 300 mg dose of tramadol - but not 100 or 200 mg doses - surpassed placebo in improving pain and function related to hip or knee osteoarthritis, but was linked to...
1 month ago - Healio
‘Social prescribing' may help lonely older adults to avoid harmful sedatives and painkillers
Lonely, older adults are nearly twice as likely to use opioids to ease pain and two-and-a-half times more likely to use sedatives and anti-anxiety medications, putting...
1 month ago - News Medical
FDA Leaders, Advisory Panel Go Head-to-Head Over Aducanumab
FDA leaders and members of the advisory panel that recommended against approval of the controversial Alzheimer's drug aducanumab have gone head-to-head in two perspectives...
1 month ago - Medscape
Biogen accused of over-marketing controversial new Alzheimer's drug Aduhelm
Biogen is under fire once again because of their controversial Alzheimer's drug, Aduhelm. An online survey published by the company recommends people for a cognitive screening...
1 month ago - Daily Mail
Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign
Do you sometimes lose your train of thought or feel a bit more anxious than is typical for you?
1 month ago - News Medical
To Pay or Not to Pay: Medicare's Big Aduhelm Decision
In June, the FDA approved aducanumab to treat patients with Alzheimer's disease using the agency's accelerated approval pathway, despite significant concerns about the evidence...
1 month ago - MedPageToday
Biogen research chief says 'misinformation' is cause for controversy surrounding Alzheimer's drug
Biogen R&D chief says that misinformation is at the heart of the controversy surrounding Aduhelm, his companies newly approved Alzheimer's drug.
1 month ago - Daily Mail
New digital health technologies could lead to better care for Parkinson's disease
The use of digital health technologies across health care and drug development has accelerated. A new paper titled "Digital Progression Biomarkers as Novel Endpoints in...
1 month ago - News Medical - 2 articles
The Stakes of an FDA Probe on New Alzheimer's Drug
On June 7, the FDA approved a new Alzheimer's drug, aducanumab. Numerous scientists, clinicians, bioethicists, and policymakers have serious concerns about the drug's efficacy...
1 month ago - MedPageToday - 2 articles
Smoking-Parkinson's Link; Kids, COVID, and Neurologic Outcomes; Z-Drugs and Opioids
Smoking was a protective factor against Parkinson's disease in a Mendelian randomization study, but only when current versus former smokers were compared. Osmophobia - an...
1 month ago - MedPageToday
Free Registration
The headlines of Master Doctor
AP-NORC Poll on Community Support of Older Adults Finds Disparities in...
Overall, more people think their local area is doing a good job than a poor job meeting the needs of older adults when it comes to many services, including health care, healthy...
Strength Training for Bone Density: How Much Benefit Can You Expect?
If you're a woman over 50, you may be tempted to forgo strength training and stay physically active in other ways, like walking or cycling. However, these exercises aren't high...
High sugar intake may increase risk for Alzheimer's disease
Total sugar intake may affect cognitive function over time, with higher amounts potentially increasing risk for Alzheimer's disease, according to study results presented at the...
Optimization of modifiable factors may prevent persistently poor knee confidence
By addressing modifiable factors, clinicians may prevent a long-term course of persistently poor knee confidence in patients with or at elevated risk for knee osteoarthritis...